Literature DB >> 14747631

Cerebrovascular reactivity in major depression: a pilot study.

Peter Neu1, Peter Schlattmann, Andreas Schilling, Andreas Hartmann.   

Abstract

OBJECTIVE: There are a growing number of reports that depression may increase the risk of stroke. Little is known, however, about the pathophysiologic mechanisms underlying this association. Cerebrovascular reactivity (CVR) reflects the compensatory dilatory capacity of cerebral arterioles to a dilatory stimulus and is an important mechanism to provide constant cerebral blood flow. We hypothesized that CVR is reduced in patients with major depression, thus contributing to the association between depression and stroke.
METHODS: We assessed CVR in 33 patients with unipolar depression and 26 healthy controls by calculating the increase in cerebral blood flow velocity after stimulation with acetazolamide. Blood flow velocities were measured by transcranial Doppler ultrasound.
RESULTS: Cerebrovascular reactivity was significantly reduced in depressed patients. Smoking was also associated with a significant reduction in CVR, whereas age and gender had no significant influence.
CONCLUSIONS: Cerebrovascular reactivity appears to be impaired in major depression. Further studies should clarify the mechanisms leading to this reduced CVR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747631     DOI: 10.1097/01.psy.0000107880.03026.54

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  15 in total

Review 1.  [Post-stroke depression: clinical aspects, epidemiology, therapy, and pathophysiology].

Authors:  G Kronenberg; J Katchanov; M Endres
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

Review 2.  Update on depression in neurologic illness: stroke, epilepsy, and multiple sclerosis.

Authors:  Richard M Sobel; Susan Lotkowski; Steven Mandel
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

3.  Depressive symptoms predict incident stroke independently of memory impairments.

Authors:  M M Glymour; J Maselko; S E Gilman; K K Patton; M Avendaño
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

4.  Frontocingulate cerebral blood flow and cerebrovascular reactivity associated with antidepressant response in late-life depression.

Authors:  Margarita Abi Zeid Daou; Brian D Boyd; Manus J Donahue; Kimberly Albert; Warren D Taylor
Journal:  J Affect Disord       Date:  2017-03-16       Impact factor: 4.839

5.  Brain changes associated with thromboxane receptor antagonist SQ 29,548 treatment in a mouse model.

Authors:  Andrew A Rebel; Siri A Urquhart; Kendra L Puig; Atreyi Ghatak; Stephen A Brose; Mikhail Y Golovko; Colin K Combs
Journal:  J Neurosci Res       Date:  2015-02-22       Impact factor: 4.164

6.  Dietary Phytoestrogen Intake and Cognitive Status in Southern Italian Older Adults.

Authors:  Francesca Giampieri; Justyna Godos; Giuseppe Caruso; Marcin Owczarek; Joanna Jurek; Sabrina Castellano; Raffaele Ferri; Filippo Caraci; Giuseppe Grosso
Journal:  Biomolecules       Date:  2022-05-30

7.  Assessment of cerebrovascular reactivity during major depression and after remission of disease.

Authors:  Alireza Vakilian; Farhad Iranmanesh
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

Review 8.  [Correlation of depression with stroke. Pathophysiological mechanisms].

Authors:  P Neu
Journal:  Nervenarzt       Date:  2009-07       Impact factor: 1.214

9.  Anterior-posterior gradient differences in lobar and cingulate cortex cerebral blood flow in late-life depression.

Authors:  Margarita Abi Zeid Daou; Brian D Boyd; Manus J Donahue; Kimberly Albert; Warren D Taylor
Journal:  J Psychiatr Res       Date:  2017-11-11       Impact factor: 4.791

10.  Cerebrovascular reactivity is blunted in young adults with major depressive disorder: The influence of current depressive symptomology.

Authors:  Ashley M Darling; Rauchelle E Richey; John D Akins; Erika F H Saunders; R Matthew Brothers; Jody L Greaney
Journal:  J Affect Disord       Date:  2021-08-29       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.